| Document Date: 2015-01-02 12:59:52
Open Document File Size: 94,85 KBShare Result on Facebook
Company Eli Lilly / J&J / Merck / Vertex / AstraZeneca / / Event Product Issues / FDA Phase / Product Recall / / Facility Specialty Pharmacy / Pharmacy Intern / / IndustryTerm Hepatitis C therapy / e-prescribing / Hepatitis C treatment / / MedicalCondition Cystic Fibrosis AND / peripheral arterial disease / cold sores / Hepatitis C / cystic fibrosis / long term chronic use / asthma / insulin resistance / disease / hypertriglyceridemia / diabetes AND / myocardial infarction / recurrent herpes labialis / depression / / MedicalTreatment insufflation / / Organization Substance Abuse Unit / Clinical Call Center / DUR Board / FDA / Access Pharmacy Benefit Management Program DUR Board / / Person Michael Biddle / Carrie Germaine / Mark Pasanen / Mary Beth Bizzari / Rick Angeli / Kim Ladue / Michelle Sirois / Catamaran Nancy / Olivia Lee / Thomas Currier / Diane Neal / James Marmar / Michelle Mattox / Amanda Kennedy / Gary Starecheski / Session / Stacey Baker / Joseph Lasek / Rod Francisco / Nancy Hogue / Scott Williams / Arlene Price / Kristen Chopas / Scott Strenio / Sarah Kidd / Wendy Pollinger / Catamaran Nancy Hogue / Janet Farina / Kristen Bruno-Doherty / Jaskanwar Batra / Timothy Chatas / Michelle Maddox / Rita Baglini / / Position Director Update / Medical Director / DVHA Medical Director for final approval / Director approval / Executive / Chair / Miner / / Product Extended Release Oral Tablet / acyclovir / Androgel / Buccal Tablet / Oral Tablet / Alcohol / Diazepam / Naloxone / Suboxone / Subcutaneous Injection / Testosterone / Vivitrol / clopidogrel / Alprazolam / Xolair / valacyclovir / Sitavig® / Zohydro® ER / New Drug / Myalept® / Zontivity® (vorapaxar) Oral / Kalydeco® (ivacaftor) Oral / / ProvinceOrState Vermont / / Technology Genotype / /
SocialTag |
Department of Vermont Health Access Pharmacy Benefit Management Program DUR Board Meeting Minutes: [removed]Board Members: Present: Joseph Lasek, MD, Chair